(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -75.08%4.54M | -14.18%20.28M | 143.38%9.03M | -80.77%-7.46M | -0.79%504K | -22.67%18.2M | -74.82%23.63M | -79.86%3.71M | -116.25%-4.12M | -97.68%508K |
Net income from continuing operations | -52.98%4.27M | -22.68%3.38M | 342.38%3.88M | -30.41%-5.79M | 25.20%-3.79M | -41.35%9.09M | -89.02%4.37M | -118.02%-1.6M | -152.76%-4.44M | -143.77%-5.07M |
Operating gains losses | 398.29%583K | -364.07%-775K | 58.79%-410K | -36.50%1.26M | -362.86%-1.75M | 114.92%117K | -113.57%-167K | -197.84%-995K | 290.00%1.99M | -773.21%-377K |
Depreciation and amortization | 15.81%5.77M | 0.36%20.44M | -0.46%5.24M | 1.31%5.19M | -0.59%5.03M | 1.24%4.99M | 13.08%20.37M | 5.41%5.26M | 18.50%5.13M | 17.08%5.06M |
Asset impairment expenditure | ---- | -94.11%708K | -96.62%387K | --321K | --0 | ---- | 1,323.70%12.02M | --11.47M | --0 | --0 |
Remuneration paid in stock | 2.95%279K | 12.02%1.15M | 8.15%292K | 10.27%290K | 3.90%293K | 30.29%271K | 55.00%1.02M | 38.46%270K | 39.89%263K | 50.00%282K |
Deferred tax | 53.12%-991K | -190.89%-4.88M | -154.66%-862K | 28.66%-351K | 49.73%-1.56M | -734.83%-2.11M | -116.36%-1.68M | -68.91%1.58M | -5.81%-492K | -321.21%-3.1M |
Other non cashItems | -67.81%273K | 323.08%2.3M | 183.19%287K | 874.14%1.7M | 29.14%-530K | 857.14%848K | 25.13%-1.03M | 75.18%-345K | -83.89%174K | -31.23%-748K |
Change In working capital | -212.90%-5.65M | 81.91%-2.04M | 101.82%217K | -49.41%-10.07M | -37.06%2.81M | 71.10%5.01M | -146.22%-11.28M | -3,315.76%-11.92M | -159.58%-6.74M | -7.76%4.46M |
-Change in receivables | -209.56%-7.12M | 1,508.61%5.89M | 95.42%-385K | 68.39%-886K | -93.69%660K | 1,840.00%6.5M | -105.77%-418K | 10.76%-8.42M | -138.41%-2.8M | 200.20%10.47M |
-Change in inventory | -381.62%-521K | 162.48%1.96M | 60.24%-794K | 298.90%1.26M | 0.69%1.31M | 110.29%185K | -223.89%-3.13M | -210.09%-2M | -135.40%-634K | 614.29%1.3M |
-Change in payables and accrued expense | 119.76%1.11M | -503.91%-10.18M | -19.93%-3.83M | -1,122.86%-6.8M | 290.91%6.07M | -239.89%-5.62M | -114.32%-1.69M | -154.06%-3.19M | -81.55%665K | -313.07%-3.18M |
-Change in other current liabilities | -77.80%876K | 104.92%297K | 210.52%5.22M | 8.16%-3.65M | -26.81%-5.23M | 966.49%3.95M | -161.40%-6.04M | 90.92%1.68M | -559.91%-3.97M | -195.66%-4.12M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -75.08%4.54M | -14.18%20.28M | 143.38%9.03M | -80.77%-7.46M | -0.79%504K | -22.67%18.2M | -74.82%23.63M | -79.86%3.71M | -116.25%-4.12M | -97.68%508K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 74.24%-1.13M | -72.20%-16.89M | 2.07%-2.51M | -186.82%-5.2M | -59.17%-4.79M | -81.19%-4.38M | -21.01%-9.81M | 43.42%-2.56M | 69.88%-1.81M | -258.76%-3.01M |
Net PPE purchase and sale | 74.24%-1.13M | -72.20%-16.89M | 2.07%-2.51M | -186.82%-5.2M | -59.17%-4.79M | -81.19%-4.38M | 17.97%-9.81M | 43.42%-2.56M | 69.88%-1.81M | -258.76%-3.01M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 74.24%-1.13M | -72.20%-16.89M | 2.07%-2.51M | -186.82%-5.2M | -59.17%-4.79M | -81.19%-4.38M | -21.01%-9.81M | 43.42%-2.56M | 69.88%-1.81M | -258.76%-3.01M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 31.80%-5.26M | 30.59%-24.91M | 37.25%-3.38M | 6.74%-5.77M | 44.14%-8.04M | 22.18%-7.72M | 4.40%-35.89M | 69.91%-5.39M | -187.01%-6.19M | -36.13%-14.39M |
Net issuance payments of debt | -830.85%-1.75M | 36.23%-5.13M | 106.09%234K | --0 | -40.03%-5.17M | 33.57%-188K | 68.14%-8.04M | 31.52%-3.85M | 89.89%-218K | 65.06%-3.7M |
Net common stock issuance | --0 | 78.72%-2.61M | --0 | --0 | 91.45%-757K | 45.64%-1.85M | -38.71%-12.26M | --0 | --0 | ---8.85M |
Cash dividends paid | -0.44%-3.65M | 7.01%-14.64M | 2.02%-3.64M | 3.49%-3.65M | 8.81%-3.71M | 12.89%-3.64M | -456.42%-15.74M | -31.35%-3.72M | ---3.79M | ---4.07M |
Proceeds from stock option exercised by employees | -31.43%72K | -29.66%102K | --0 | --0 | -108.33%-3K | -4.55%105K | 72.62%145K | -101.19%-1K | --0 | --36K |
Net other financing activities | 103.17%68K | -44,100.00%-2.64M | -98.94%23K | 3.07%-2.12M | -26.74%1.6M | 0.79%-2.15M | 100.83%6K | --2.17M | ---2.19M | --2.18M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 31.80%-5.26M | 30.59%-24.91M | 37.25%-3.38M | 6.74%-5.77M | 44.14%-8.04M | 22.18%-7.72M | 4.40%-35.89M | 69.91%-5.39M | -187.01%-6.19M | -36.13%-14.39M |
Net cash flow | ||||||||||
Beginning cash position | -57.04%16.25M | -36.75%37.82M | -68.60%13.13M | -40.26%31.68M | -38.22%43.92M | -36.75%37.82M | 324.51%59.79M | -35.62%41.81M | 8.41%53.02M | 83.98%71.1M |
Current changes in cash | -130.44%-1.86M | 2.48%-21.52M | 173.88%3.14M | -51.98%-18.43M | 27.04%-12.33M | -45.54%6.1M | -145.78%-22.07M | -5.46%-4.25M | -170.48%-12.13M | -261.08%-16.9M |
Effect of exchange rate changes | -29,600.00%-590K | -154.64%-53K | -107.87%-20K | -112.51%-115K | 106.79%80K | -98.06%2K | 103.89%97K | 122.54%254K | 178.68%919K | -428.70%-1.18M |
End cash Position | -68.58%13.8M | -57.04%16.25M | -57.04%16.25M | -68.60%13.13M | -40.26%31.68M | -38.22%43.92M | -36.75%37.82M | -36.75%37.82M | -35.62%41.81M | 8.41%53.02M |
Free cash from | -75.35%3.41M | -75.46%3.39M | 468.53%6.52M | -113.17%-12.66M | -71.34%-4.29M | -34.57%13.82M | -83.12%13.82M | -91.74%1.15M | -130.67%-5.94M | -111.88%-2.5M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.